Show simple item record

dc.contributor.authorMa, Yunsheng
dc.contributor.authorCulver, Annie L.
dc.contributor.authorRossouw, Jacques E.
dc.contributor.authorOlendzki, Barbara C.
dc.contributor.authorMerriam, Philip A.
dc.contributor.authorLian, Bill
dc.contributor.authorOckene, Ira S.
dc.date2022-08-11T08:10:21.000
dc.date.accessioned2022-08-23T17:05:21Z
dc.date.available2022-08-23T17:05:21Z
dc.date.issued2013-02-01
dc.date.submitted2013-01-18
dc.identifier.citationTher Adv Cardiovasc Dis. 2013 Feb;7(1):41-4. doi: 10.1177/1753944712468499. <a href="http://dx.doi.org/10.1177/1753944712468499" target="_blank">Link to article on publisher's site</a>
dc.identifier.issn1753-9447 (Linking)
dc.identifier.doi10.1177/1753944712468499
dc.identifier.pmid23238515
dc.identifier.urihttp://hdl.handle.net/20.500.14038/44839
dc.description.abstractPurpose of review: The purpose of this review was to examine statin therapy and the risk for diabetes among adult women using a selective review. Recent findings: The literature contains reports of new-onset diabetes associated with statin use. While many studies do not report sex-specific results, there is evidence indicating the risk to benefit ratio may vary by gender. However, the absolute effects are not clear because women have historically been under-represented in clinical trials. Summary: A review of the literature indicates that the cardiovascular benefits of statins appear to outweigh the risk for statin-related diabetes. However, the effect may depend upon baseline diabetes risk, dose, and statin potency. Rigorous, long-term studies focused on the risks and benefits of statins in women are unavailable to sort for gender-specific differences. Until this changes, individualized attention to risk assessment, and strong prevention with lifestyle changes must prevail.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=23238515&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1177/1753944712468499
dc.subjectDiabetes Mellitus, Type 2
dc.subjectHydroxymethylglutaryl-CoA Reductase Inhibitors
dc.subjectCardiovascular Diseases
dc.subjectCommunity Health and Preventive Medicine
dc.subjectDigestive System Diseases
dc.subjectEndocrine System Diseases
dc.subjectPreventive Medicine
dc.subjectWomen's Health
dc.titleStatin therapy and the risk for diabetes among adult women: do the benefits outweigh the risk
dc.typeJournal Article
dc.source.journaltitleTherapeutic advances in cardiovascular disease
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/prevbeh_pp/261
dc.identifier.contextkey3588915
html.description.abstract<p>Purpose of review: The purpose of this review was to examine statin therapy and the risk for diabetes among adult women using a selective review.</p> <p>Recent findings: The literature contains reports of new-onset diabetes associated with statin use. While many studies do not report sex-specific results, there is evidence indicating the risk to benefit ratio may vary by gender. However, the absolute effects are not clear because women have historically been under-represented in clinical trials.</p> <p>Summary: A review of the literature indicates that the cardiovascular benefits of statins appear to outweigh the risk for statin-related diabetes. However, the effect may depend upon baseline diabetes risk, dose, and statin potency. Rigorous, long-term studies focused on the risks and benefits of statins in women are unavailable to sort for gender-specific differences. Until this changes, individualized attention to risk assessment, and strong prevention with lifestyle changes must prevail.</p>
dc.identifier.submissionpathprevbeh_pp/261
dc.contributor.departmentDepartment of Medicine, Division of Cardiovascular Medicine
dc.contributor.departmentDepartment of Medicine, Division of General Medicine
dc.contributor.departmentDepartment of Medicine, Division of Preventive and Behavioral Medicine


This item appears in the following Collection(s)

Show simple item record